SMS Lifesciences India Limited
SMSLIFE.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.73B
Close$
Share Statistics
| Market cap | $4.73 Billion |
|---|---|
| Enterprise Value | $5.82 Billion |
| Dividend Yield | $1.50 (0.10%) |
| Earnings per Share | $57.26 |
| Beta | 0.31 |
| Outstanding Shares | 3,026,000 |
Return
| Return on Equity | 7.40% |
|---|---|
| Return on Assets | 3.48% |
| Return on Invested Capital | 8.53% |
Valuation & Multiples
| P/E Ratio | 29.92 |
|---|---|
| PEG | -82.34 |
| Price to Sales | 1.21 |
| Price to Book Ratio | 1.71 |
| Enterprise Value to Revenue | 1.8 |
| Enterprise Value to EBIT | 22.89 |
| Enterprise Value to Net Income | 36 |
| Total Debt to Enterprise | 0.19 |
| Debt to Equity | 0.52 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Haleos Labs Limited
611 employees
CEO: Talluri Veera Venkata Satyanarayana Murthy Haleos Labs Limited, established in 1990 and headquartered in Hyderabad, India, focuses on the manufacture of active pharmaceutical ingredients (APIs) and their chemical intermediates. Primarily operating within India, the company produc...